Evidence map›Paper›PMID 41889687›Full record

ReviewVascular health and risk management2026

Cerebrovascular Manifestations of Neurosarcoidosis - An Overview.

Praveen Kesav, Anu Jacob, Syed Irteza Hussain, Seby John

Abstract readReview
In one paragraph

Review in Vascular health and risk management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Praveen KesavDepartment of Neurology, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Anu JacobDepartment of Neurology, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Syed Irteza HussainDepartment of Neurology and Neurointerventional Surgery, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Seby JohnDepartment of Neurology and Neurointerventional Surgery, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurosarcoidosis (NS) is defined as involvement of either central or peripheral nervous system by non-caseating granulomatous inflammation. They are seen clinically in 5-10% of those with sarcoidosis, though sub-clinical involvement is commoner. Cerebrovascular manifestations of neurosarcoidosis (CVNS) are considered even rarer but availability of novel imaging techniques and awareness of potential imaging markers for NS (yet to be validated), has resulted in better recognition. CVNS can occasionally be the presenting manifestation of sarcoidosis. Despite being rare, those with CVNS may have higher morbidity and mortality compared to other forms of NS. In this review, we aim to describe the clinical features, approach to diagnosis, mimics, investigation and management of CVNS, while attempting to identify features that differentiate central nervous system vasculitis associated with NS (CNSV-NS) from primary central nervous system vasculitis (PCNSV), a close diagnostic mimic.

Indexed as

Central Nervous System DiseasesCerebrovascular DisordersSarcoidosisDiagnosis, DifferentialHumansPredictive Value of TestsPrognosisRisk FactorsVasculitis, Central Nervous Systemcerebrovascular neurosarcoidosisneurosarcoidosisNSstrokevasculitis

Identifiers

PMID41889687
PMCPMC13016095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.